While many of these venture-backed startups label themselves as pharmaceutical companies, their efforts have largely concentrated on developing versatile nanoscale delivery platforms that can incorporate different therapeutics, targeting technologies and other functions according to need.

FORBES: Nanotech Puts Cancer In The Cross Hairs